• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Increased Molecular Flexibility Widens the Gap between and values in Screening for Retinoid X Receptor Modulators.分子柔韧性增加扩大了类视黄醇X受体调节剂筛选中 与 值之间的差距。 (原文中两个“ ”处信息缺失)
ACS Med Chem Lett. 2022 Jan 21;13(2):211-217. doi: 10.1021/acsmedchemlett.1c00575. eCollection 2022 Feb 10.
2
Discovery of a "Gatekeeper" Antagonist that Blocks Entry Pathway to Retinoid X Receptors (RXRs) without Allosteric Ligand Inhibition in Permissive RXR Heterodimers.发现一种“守门员”拮抗剂,可阻止视黄酸 X 受体 (RXR) 的进入途径,而不会在允许的 RXR 异二聚体中产生变构配体抑制。
J Med Chem. 2021 Jan 14;64(1):430-439. doi: 10.1021/acs.jmedchem.0c01354. Epub 2020 Dec 24.
3
Retinoid X receptor-antagonistic diazepinylbenzoic acids.维甲酸X受体拮抗型二氮杂苯苯甲酸类化合物
Chem Pharm Bull (Tokyo). 1999 Dec;47(12):1778-86. doi: 10.1248/cpb.47.1778.
4
Recent Progress in the Design and Discovery of RXR Modulators Targeting Alternate Binding Sites of the Receptor.靶向受体替代结合位点的RXR调节剂的设计与发现的最新进展。
Curr Top Med Chem. 2017;17(6):663-675. doi: 10.2174/1568026616666160617092241.
5
Creation of Fluorescent RXR Antagonists Based on CBTF-EE and Application to a Fluorescence Polarization Binding Assay.基于CBTF-EE的荧光视黄酸X受体拮抗剂的创制及其在荧光偏振结合分析中的应用。
ACS Med Chem Lett. 2021 May 7;12(6):1024-1029. doi: 10.1021/acsmedchemlett.1c00201. eCollection 2021 Jun 10.
6
Retinoid X receptor (RXR) within the RXR-retinoic acid receptor heterodimer binds its ligand and enhances retinoid-dependent gene expression.视黄酸X受体(RXR)在RXR-视黄酸受体异源二聚体中结合其配体并增强视黄酸依赖性基因表达。
Mol Cell Biol. 1997 Feb;17(2):644-55. doi: 10.1128/MCB.17.2.644.
7
Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.纳曲酮衍生的吡啶并和嘧啶并吗啡喃的合成、阿片受体结合及生物活性
J Med Chem. 1999 Sep 9;42(18):3527-38. doi: 10.1021/jm990039i.
8
Convenient Retinoid X Receptor Binding Assay Based on Fluorescence Change of the Antagonist NEt-C343.基于拮抗剂 NEt-C343 荧光变化的方便型视黄醇 X 受体结合分析。
J Med Chem. 2021 Jan 14;64(1):861-870. doi: 10.1021/acs.jmedchem.0c01883. Epub 2020 Dec 30.
9
Computational analysis of the structural basis of ligand binding to the crustacean retinoid X receptor.甲壳动物视黄酸 X 受体配体结合结构基础的计算分析。
Comp Biochem Physiol Part D Genomics Proteomics. 2010 Dec;5(4):317-24. doi: 10.1016/j.cbd.2010.09.002. Epub 2010 Sep 24.
10
Radioligand binding assay for accurate determination of nuclear retinoid X receptors: A case of triorganotin endocrine disrupting ligands.用于准确测定核类视黄醇X受体的放射性配体结合分析:三有机锡内分泌干扰配体的一个案例
Toxicol Lett. 2016 Jul 8;254:32-6. doi: 10.1016/j.toxlet.2016.05.005. Epub 2016 May 3.

引用本文的文献

1
CD36-mediated endocytosis of proteolysis-targeting chimeras.CD36介导的靶向蛋白水解嵌合体的内吞作用。
Cell. 2025 Jun 12;188(12):3219-3237.e18. doi: 10.1016/j.cell.2025.03.036. Epub 2025 Apr 17.
2
Improving binding entropy by higher ligand symmetry? - A case study with human matriptase.通过提高配体对称性来改善结合熵?——以人组织激肽释放酶为例的研究
RSC Med Chem. 2023 Apr 27;14(5):969-982. doi: 10.1039/d3md00125c. eCollection 2023 May 25.

本文引用的文献

1
Creation of Fluorescent RXR Antagonists Based on CBTF-EE and Application to a Fluorescence Polarization Binding Assay.基于CBTF-EE的荧光视黄酸X受体拮抗剂的创制及其在荧光偏振结合分析中的应用。
ACS Med Chem Lett. 2021 May 7;12(6):1024-1029. doi: 10.1021/acsmedchemlett.1c00201. eCollection 2021 Jun 10.
2
Potential therapeutic uses of rexinoids.类视黄醇的潜在治疗用途。
Adv Pharmacol. 2021;91:141-183. doi: 10.1016/bs.apha.2021.01.004. Epub 2021 Mar 4.
3
Stability of the Retinoid X Receptor-α Homodimer in the Presence and Absence of Rexinoid and Coactivator Peptide.视黄醇 X 受体-α 同源二聚体在雷索昔芬和辅激活肽存在和不存在时的稳定性。
Biochemistry. 2021 Apr 20;60(15):1165-1177. doi: 10.1021/acs.biochem.0c00865. Epub 2021 Apr 1.
4
Convenient Retinoid X Receptor Binding Assay Based on Fluorescence Change of the Antagonist NEt-C343.基于拮抗剂 NEt-C343 荧光变化的方便型视黄醇 X 受体结合分析。
J Med Chem. 2021 Jan 14;64(1):861-870. doi: 10.1021/acs.jmedchem.0c01883. Epub 2020 Dec 30.
5
Discovery of a "Gatekeeper" Antagonist that Blocks Entry Pathway to Retinoid X Receptors (RXRs) without Allosteric Ligand Inhibition in Permissive RXR Heterodimers.发现一种“守门员”拮抗剂,可阻止视黄酸 X 受体 (RXR) 的进入途径,而不会在允许的 RXR 异二聚体中产生变构配体抑制。
J Med Chem. 2021 Jan 14;64(1):430-439. doi: 10.1021/acs.jmedchem.0c01354. Epub 2020 Dec 24.
6
Chemical Screening of Nuclear Receptor Modulators.核受体调节剂的化学筛选。
Int J Mol Sci. 2020 Jul 31;21(15):5512. doi: 10.3390/ijms21155512.
7
Structure-Activity Relationship Study Enables the Discovery of a Novel Analogue as the RXRα Activator to Inhibit Colon Cancer.结构-活性关系研究发现新型 RXRα 激活剂抑制结肠癌
J Med Chem. 2020 Jun 11;63(11):5841-5855. doi: 10.1021/acs.jmedchem.0c00088. Epub 2020 May 28.
8
Drug discovery technologies to identify and characterize modulators of the pregnane X receptor and the constitutive androstane receptor.鉴定和表征孕烷 X 受体和组成型雄烷受体调节剂的药物发现技术。
Drug Discov Today. 2019 Mar;24(3):906-915. doi: 10.1016/j.drudis.2019.01.021. Epub 2019 Feb 4.
9
Discovery of atorvastatin as a tetramer stabilizer of nuclear receptor RXRα through structure-based virtual screening.通过基于结构的虚拟筛选发现阿托伐他汀是核受体 RXRα 的四聚体稳定剂。
Bioorg Chem. 2019 Apr;85:413-419. doi: 10.1016/j.bioorg.2019.01.007. Epub 2019 Jan 10.
10
Interplay between Conformational Entropy and Solvation Entropy in Protein-Ligand Binding.构象熵和溶剂化熵在蛋白-配体结合中的相互作用。
J Am Chem Soc. 2019 Feb 6;141(5):2012-2026. doi: 10.1021/jacs.8b11099. Epub 2019 Jan 23.

分子柔韧性增加扩大了类视黄醇X受体调节剂筛选中 与 值之间的差距。 (原文中两个“ ”处信息缺失)

Increased Molecular Flexibility Widens the Gap between and values in Screening for Retinoid X Receptor Modulators.

作者信息

Watanabe Masaki, Nakamura-Nakayama Mariko, Fujihara Michiko, Kawasaki Mayu, Nakano Shogo, Kakuta Hiroki

机构信息

Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 1-1-1, Tsushima-naka, Kita-ku, Okayama 700-8530, Japan.

AIBIOS K.K., Tri-Seven Roppongi 8F, 7-7-7 Roppongi, Minato-ku, Tokyo 106-0032, Japan.

出版信息

ACS Med Chem Lett. 2022 Jan 21;13(2):211-217. doi: 10.1021/acsmedchemlett.1c00575. eCollection 2022 Feb 10.

DOI:10.1021/acsmedchemlett.1c00575
PMID:35178177
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8842113/
Abstract

Screening for small-molecule modulators targeting a particular receptor is frequently based on measurement of , i.e., the binding constant between the receptor and the compound of interest. However, values also reflect binding at receptor protein sites other than the modulatory site. We designed derivatives of retinoid X receptor (RXR) antagonist CBTF-EE () with modifications that altered their conformational flexibility. Compounds , and , showed quite similar values, but , exhibited 10-fold higher values than those of ,. Further, , showed potent RXR-antagonistic activity, while , were inactive. These results suggest that increased conformational flexibility promotes binding at nontarget receptor sites. In this situation, conventional determination of is less effective for screening purposes than the determination of using a ligand that binds specifically to the site regulating transcriptional activity. Thus, the use of values for orthosteric ligands may increase the hit rate in screening active regulatory molecules.

摘要

针对特定受体筛选小分子调节剂通常基于对 的测量,即受体与目标化合物之间的结合常数。然而, 值也反映了在调节位点以外的受体蛋白位点的结合情况。我们设计了视黄酸X受体(RXR)拮抗剂CBTF - EE()的衍生物,通过修饰改变其构象灵活性。化合物 、 和 显示出相当相似的 值,但 表现出比 、 高10倍的 值。此外, 显示出有效的RXR拮抗活性,而 无活性。这些结果表明,增加的构象灵活性促进了在非靶标受体位点的结合。在这种情况下,传统的 测定对于筛选目的而言不如使用特异性结合调节转录活性位点的配体来测定 有效。因此,使用正构配体的 值可能会提高筛选活性调节分子时的命中率。